Allos

We’re presenting at Berkeley SkyDeck Demo Day today! Come to our booth to say hi!

Major announcement that we are so excited to share! We'll be presenting at Berkeley SkyDeck’s Demo Day, among other game-changing early stage companies. Want to learn more? Read about it in VentureBeat. https://lnkd.in/dc7VHp_m Come to SkyDeck's Demo Day on April 10th! Secure your invite here: https://lnkd.in/gJhnw8XR #SkyDeckDemoDay

Come meet us at Berkeley SkyDeck Batch 17 Demo Day!

Revolutionising healthcare with AI 🚀. Our AI for Health cohort is pushing the boundaries of medical technology, from accelerating drug discovery to personalising patient care. These trailblazers are not just innovating; they're improving lives. Find out more about their groundbreaking work at the AI Accelerator showcase.    Don't miss out Allos, Dyneval, Eye to the Future Limited, and Sympa Health as they demonstrate the power of AI in transforming healthcare.    Read more about our AI for Health cohort innovators here:  https://edin.ac/3PDeGoV    🎟 Secure your spot, request your ticket now: https://edin.ac/3vRkkfw    Katy Guthrie   Fabrizio Formichella   Edinburgh Innovations   Data-Driven Innovation Initiative   #AIAccelerator  #AIAccelerator2024  #AIForHealth   #Innovation 

Proud to have pitched at the Berkeley Bio Showcase last week at JPM! It was an amazing event and we are very grateful for this opportunity to pitch alongside many great Berkeley startups. Go Bears!! Life Sciences Entrepreneurship Center Berkeley SkyDeck #JPM2024 #BerkeleySkydeck #BerkeleyBio #HealthTech #ClinicalTrials

🌟 Exciting news! We are excited to welcome Xue Snow G. to our team. A seasoned biotech executive, Snow is currently the Vice President of Clinical Pharmacology at BridgeBio providing strategic leadership for various clinical development programs. With extensive experience in clinical development, pharmacology, and regulatory approval, Snow will bring innovative insights into how Allos can supercharge existing clinical development programs with our Causal AI engine. We are delighted to have Snow on board as our esteemed Key Advisor as part of the prestigious Berkeley SkyDeck Cohort program and look forward to working closely with her and leveraging her invaluable expertise to drive our goal of de-risking clinical trials forward. #Allos #AllosAI #BerkeleySkyDeck #StartupAdvisor #HealthTech #PharmaAI

🌟 Exciting news! We're thrilled to welcome Laura Hix Glickman to our team. As a trained cancer immunologist and experienced biotech entrepreneur, she brings deep expertise and executive leadership. As Co-Founder and CEO of Adjuvia Therapeutics and a board member at Selva Therapeutics, Laura has already made significant contributions to the industry. Her previous work on the STING program at Aduro Biotech (NASDAQ:ADRO) showcases her scientific prowess. We are delighted to have Laura on board as our esteemed Key Advisor as part of the prestigious Berkeley SkyDeck Cohort program and look forward to her valuable insights as we work to de-risk clinical trials. #Allos #AllosAI #BerkeleySkyDeck #StartupAdvisor #HealthTech #PharmaAI

We're super excited to be attending JPM 2024 in San Francisco, from 8-11 Jan. Our team will be presenting at the first-ever Berkeley Bio Startup Showcase led by the amazing Darren Cooke! We'd love to speak with anyone who's interested in learning about our work in treatment non-response and Causal AI to de-risk clinical trials. #JPM2024 #BerkeleySkydeck #BerkeleyBio #HealthTech #ClinicalTrials

🌟 Exciting news! Join us in celebrating the newest member of our team - Scott Jablonski, a seasoned executive with a remarkable track record in tech, sports, and finance. Having made significant contributions at renowned organizations such as the NBA, NHL, and StubHub, Scott's expertise is truly unmatched. His analytical prowess and strategic mindset have left an indelible impression on the entire Allos team! We are absolutely thrilled to have him on board as our esteemed Key Advisor as part of the prestigious Berkeley SkyDeck Cohort program. #Allos #AllosAI #BerkeleySkyDeck #StartupAdvisor #HealthTech #PharmaAI